戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              S. pyogenes bound purified fibulin-1 in a dose-dependent
2                                              S. pyogenes did not release HlpA during growth in vitro;
3                                              S. pyogenes dnaX encodes only the full-length tau, unlik
4                                              S. pyogenes expresses HSA-binding surface proteins, and
5                                              S. pyogenes grew from one or both swabs for 198 (37%) of
6                                              S. pyogenes IMPDH is a tetramer with its four subunits r
7                                              S. pyogenes MHC class II-bound peptide-specific CD4(+) T
8                                              S. pyogenes strains with this type of polymorphism cause
9                                              S. pyogenes-induced Th17 formation depended on TGF-beta1
10 C and 30 S. aureus, 15 S. pneumoniae, and 15 S. pyogenes isolates by disk diffusion (DD) methods.
11 was insertionally inactivated in an M type 2 S. pyogenes strain, T2MR.
12 e against challenge infections with M type 2 S. pyogenes.
13     In all, 1,800 Staphylococcus aureus, 259 S. pyogenes, 226 Streptococcus pneumoniae, 93 Enterococc
14 2 opsonized SOF-positive M type 2, 4, and 28 S. pyogenes in human blood but had no effect on SOF-nega
15 d but had no effect on SOF-negative M type 5 S. pyogenes.
16                                 M/emm type 6 S. pyogenes has intrinsic reduced susceptibility to fluo
17       Additionally, we analyzed M/emm type 6 S. pyogenes isolated during 1918-2003 from diverse locat
18 rated in erythromycin-resistant M/emm type 6 S. pyogenes, which raises concern for the emergence of m
19 ysis shows that in contrast to the type II-A S. pyogenes Cas9 that is widely used for genome engineer
20        Finally, we demonstrated that sloR, a S. pyogenes gene that closely resembles the Clostridium
21  show macrolide resistance (S. aureus A5177, S. pyogenes PIU2584, and S. pneumoniae 5649).
22 t SOF evokes bactericidal antibodies against S. pyogenes in humans, rabbits, and mice.
23       Biotin tagged whole antibodies against S. pyogenes were conjugated to Ptyr amine group via biot
24 gm shift from type-specific immunity against S. pyogenes to emm-cluster based immunity for this bacte
25 agent, compound 1 (MIC: 12-25 microM against S. pyogenes).
26 f the human adaptive immune response against S. pyogenes in both children and adults.
27         Thus, human immune responses against S. pyogenes consist of a robust Th1 cellular memory resp
28            We found that FH6-7/Fc alleviated S. pyogenes-induced sepsis in a transgenic mouse model e
29 istance to macrolides and tetracycline among S. pyogenes isolates in San Francisco County and shows t
30 se-dependent manner, suggesting a role as an S. pyogenes virulence factor.
31 examine this, we analyzed the behavior of an S. pyogenes mutant deficient in expression of the cytoly
32 nally, an allelic replacement analysis of an S. pyogenes strain with a naturally occurring insertion
33 ant to in vitro penetration by S. aureus and S. pyogenes and partially resistant to P. aeruginosa.
34  also prevented penetration by S. aureus and S. pyogenes; NeoForm was less effective in withstanding
35 ar adhesion and entry for B. burgdorferi and S. pyogenes.
36 tween S. dysgalactiae subsp. equisimilis and S. pyogenes alleles revealed a history of interspecies r
37  aureus was not found by culture or PCR, and S. pyogenes was not identified by any technique.
38 quences from two of these, S. pneumoniae and S. pyogenes.
39 topes contained in HIV, M. tuberculosis, and S. pyogenes.
40 he surface of Gram-positive bacteria such as S. pyogenes will enable professional phagocytes to elimi
41 y can be applied for specific agents such as S. pyogenes, or commercial multiplex NAATs for detection
42                       All cluster-associated S. pyogenes isolates were genotype emm1 and were initial
43                        The highly attenuated S. pyogenes mutant, SalY, was identified from a transpos
44                Genomic analyses of available S. pyogenes genomes revealed the presence of intact gene
45                                      Because S. pyogenes is known to release LTA and secrete at least
46                             However, because S. pyogenes are only found in humans, how are new phages
47 c toxin B (SPE B) on the interaction between S. pyogenes strain NZ131 (serotype M49) and mammalian ce
48 en grown in sugar-limited Todd-Hewitt broth, S. pyogenes cells remained culturable for more than 1 ye
49 ds, the induction of caspase-1 activation by S. pyogenes did not require exogenous ATP or the P2X7R.
50              Two postpartum deaths caused by S. pyogenes occurred within 24 h; one was characterized
51 ft-tissue infection or bacteraemia caused by S. pyogenes, and it could have a protective role in muri
52 ovel vaccine to prevent infections caused by S. pyogenes.
53 crobiological diagnosis of empyema caused by S. pyogenes.
54 t to promote invasion of epithelial cells by S. pyogenes.
55 ut also for invasion of endothelial cells by S. pyogenes.
56 in that may function in host colonization by S. pyogenes.
57                            When expressed by S. pyogenes, PFO, like SLO, had the ability to form func
58                         SpyCEP expression by S. pyogenes hindered bacterial clearance from muscle, an
59 that fluoride causes decreased expression by S. pyogenes proteins used to respond to stress, virulenc
60  IFN-beta, which is significantly induced by S. pyogenes 23S rRNA in an Irf5-dependent manner.
61 required Myd88/Trif, whereas that induced by S. pyogenes was blocked by inhibition of NF-kappaB.
62  cells prevented nasopharyngeal infection by S. pyogenes, but not by Streptococcus pneumoniae, a bact
63 y-phase culture supernatant proteins made by S. pyogenes NZ131 rgg and NZ131 speB were separated by t
64      We hypothesize that SpyA is produced by S. pyogenes to disrupt cytoskeletal structures and promo
65 Binding of complement regulatory proteins by S. pyogenes has previously been attributed to the strept
66 ed proteomic analysis of protein released by S. pyogenes into the culture supernatant and observed de
67 , and NaCl may mimic relevant cues sensed by S. pyogenes during infection; and that identification of
68 y, we investigate hemoprotein utilization by S. pyogenes.
69                       Moraxella catarrhalis, S. pyogenes, and culture-negative episodes were also sig
70              In this report, we characterize S. pyogenes DnaE polymerase and find that it is highly e
71 ellular expression of two well-characterized S. pyogenes virulence factors.
72               Finally, we assess comparative S. pyogenes and S. aureus Cas9 specificity using GUIDE-s
73 udy, we quantitatively analyzed and compared S. pyogenes proteins in the growth medium of a strain th
74 sing bioinformatics analysis of the complete S. pyogenes strain SF370 genome, we have identified a no
75 gest that under certain in vitro conditions, S. pyogenes cells can persist for greater than 1 year as
76 rtion of IgG-reactive proteins from cultured S. pyogenes are secreted.
77 ly larger amounts of the secreted cytotoxins S. pyogenes NADase (SPN) and streptolysin O (SLO).
78 ensors were also able to specifically detect S. pyogenes in 50% (v/v) human saliva, with good selecti
79 , illustrating the intrinsic ability of emm1 S. pyogenes to spread while retaining virulence.
80 we successfully delivered a plasmid encoding S. pyogenes Cas9 and sgRNA to the corneal epithelium by
81  binding to fibronectin (Fn) and facilitates S. pyogenes adherence and penetration into cells.
82 ae (Group B streptococci, GBS), E. faecalis, S. pyogenes, S. gordonii, and E. coli containing pDC123
83  transgenic mouse model expressing human FH (S. pyogenes binds FH in a human-specific manner).
84 e clinical settings, by a throat culture for S. pyogenes to increase the sensitivity of its detection
85 roxidase in S. pyogenes and is essential for S. pyogenes pathogenesis in several murine models that m
86 enized murine vaginal colonization model for S. pyogenes.
87 based system as a standard typing scheme for S. pyogenes will facilitate the design of future studies
88 his protein, the hlpA genes were cloned from S. pyogenes, S. gordonii, S. mutans, and S. sobrinus, us
89 often highly related, but they differed from S. pyogenes, in that S. dysgalactiae subsp. equisimilis
90 strate that the multidomain protein Epf from S. pyogenes serotype M49 is a streptococcal adhesin.
91 nce analyses of larger regions of FnBPs from S. pyogenes and S. aureus reveal a repeating pattern of
92 his is the first methyltransferase gene from S. pyogenes to be cloned and to have its activity charac
93 o compare cytoplasmic proteins isolated from S. pyogenes wild-type strain NZ131 (serotype M49) to pro
94 sphoribosyltransferase activity of NadC from S. pyogenes allows the organism to sustain growth when Q
95  from those recognized by Cas9 proteins from S. pyogenes and S. thermophilus (SpCas9 and StCas9, resp
96 rated cellular and supernatant proteins from S. pyogenes cultures by high-resolution two-dimensional
97 regions of fibronectin-binding proteins from S. pyogenes, S. dysgalactiae, and S. equisimilis.
98  28-kDa streptococcal protease purified from S. pyogenes processed the 40-kDa mutant zymogen to a 28-
99 ial pathogen the group A Streptococcus (GAS; S. pyogenes) as a model organism, we review the types an
100 and virulence in group A Streptococcus (GAS; S. pyogenes), the precise role of the co-transcribing se
101                                           In S. pyogenes, mutS and mutL are organized on a polycistro
102                                           In S. pyogenes, Rgg influences the expression of several vi
103  an insertionally inactivated degP allele in S. pyogenes is similar to that reported for E. coli, wit
104 sly identified as cell surface associated in S. pyogenes.
105 sion, the elucidation of GAC biosynthesis in S. pyogenes reported here enhances our understanding of
106 tion by the Rgg2/3 quorum-sensing circuit in S. pyogenes.
107       Such genetic elements may be common in S. pyogenes since 6 of 13 completed genomes have related
108  Taken together, the CvfA-enolase complex in S. pyogenes is involved in the regulation of virulence g
109 e rgg mutant with an intact rgg gene copy in S. pyogenes NZ131 could restore SPE B production and con
110                Resistance to erythromycin in S. pyogenes can be as high as 48% in specific population
111 uitry governing virulence gene expression in S. pyogenes and its impact on pathogenesis.
112 to coregulate virulence factor expression in S. pyogenes.
113 pA, the gene which encodes trigger factor in S. pyogenes, produced mutant proteins deficient in PPIas
114 istence of a new global regulatory factor in S. pyogenes.
115 side cells, and the cellular role of GdpP in S. pyogenes has not been examined yet.
116 ociated with inactivation of the rgg gene in S. pyogenes strain NZ131 (serotype M49).
117 he first hemoprotein receptors identified in S. pyogenes; their possible role in iron capture is disc
118 he rgg gene was insertionally inactivated in S. pyogenes NZ131, which resulted in markedly decreased
119 standing of the function of the sal locus in S. pyogenes pathogenesis.
120                                 Thus, MMR in S. pyogenes SF370 is functional in exponentially growing
121 S, coordinate the transcriptional network in S. pyogenes.
122 eparate entries to a final common pathway in S. pyogenes virulence gene expression.
123 idase is the major glutathione peroxidase in S. pyogenes and is essential for S. pyogenes pathogenesi
124 acterized an intergenic VNTR polymorphism in S. pyogenes that affects toxin production and virulence.
125 gy and the function of VNTR polymorphisms in S. pyogenes.
126 e and lincosamide antibiotics are present in S. pyogenes strains in the United States.
127 itate further study of cellular processes in S. pyogenes.
128 ainst sHIP suggest a role for the protein in S. pyogenes pathogenesis.
129 rify the function of HSA-binding proteins in S. pyogenes and underline the power of the quantitative
130      Macrolide and lincosamide resistance in S. pyogenes is mediated by several different genes.
131 ion of NadD confirmed its functional role in S. pyogenes, and its potential as an antibacterial targe
132        We investigated the role of SpyCEP in S. pyogenes necrotizing fasciitis and respiratory tract
133  or induced resistance to peroxide stress in S. pyogenes, genes for a novel mechanism of managing per
134 , and removal of read-through transcripts in S. pyogenes.
135  Here, we demonstrate that nuclease-inactive S. pyogenes CRISPR/Cas9 can bind RNA in a nucleic-acid-p
136 m by which Gram-positive bacteria, including S. pyogenes, coordinate multiple environmental cues, all
137 , and some Gram-positive pathogens including S. pyogenes use this cyclic nucleotide derivative as a s
138 gainst most streptococcal species, including S. pyogenes, S. agalactiae, S. dysgalactiae, S. equi, S.
139 hat M. catarrhalis can dramatically increase S. pyogenes adherence to human epithelial cells and that
140 ne of these inhibitors efficiently inhibited S. pyogenes NadD (sp.NadD) in vitro (50% inhibitory conc
141 a promoter-lacZ fusions were introduced into S. pyogenes via a bacteriophage-derived site-specific in
142 signaling protects the host against invasive S. pyogenes infection by restricting inflammation-driven
143 identified across four contemporary invasive S. pyogenes serotypes (M1, M3, M12 and M89).
144  pooled human immunoglobulin during invasive S. pyogenes infection, and demonstrate a potential route
145 t insights into the pathogenesis of invasive S. pyogenes infections.
146 ernatants prepared from cultures of invasive S. pyogenes strains of varying serotypes in the stationa
147  and the finding that patients with invasive S. pyogenes infection respond with antibody production a
148 ysis of samples from a patient with invasive S. pyogenes infection revealed dramatic differences in t
149   The utility of our model for investigating S. pyogenes factors contributing to mucosal carriage was
150 retion were induced by live, but not killed, S. pyogenes, and required expression of the pore-forming
151 d we evaluated the expression of other known S. pyogenes virulence factors.
152 tudy it is shown that AspA from serotype M28 S. pyogenes, when expressed on surrogate host Lactococcu
153                                    Since M49 S. pyogenes strains have been known to be associated wit
154  SPN and SLO in epidemic serotype M1 and M89 S. pyogenes strains is associated with rapid intercontin
155 0% S), and MIC(90)s ranged from 0.03 mug/ml (S. pyogenes/S. pneumoniae) to 1 mug/ml (Enterobacteriace
156 eutrophil extracellular traps, and modulates S. pyogenes virulence.
157                    Both wild-type and mutant S. pyogenes bacteria were extremely sensitive to low pH.
158 ht of reports of hypervirulent SpeB-negative S. pyogenes variants present during invasive infections.
159 s required for survival of L. lactis but not S. pyogenes.
160    In conclusion, we have identified a novel S. pyogenes enzyme with 5'-nucleotidase activity and imm
161 ain SF370 genome, we have identified a novel S. pyogenes virulence factor, which we termed streptococ
162                                          Now S. pyogenes NAATs are being used with increasing frequen
163 mbinant SOF from M types 2, 4, 28, and 75 of S. pyogenes, indicating that the fibulin-1-binding domai
164 nsporter may be an example of the ability of S. pyogenes to adapt and evolve new survival strategies
165  of zinc homeostasis inhibits the ability of S. pyogenes to cause disease in a zinc-limited host mili
166 s rescued, demonstrating that the ability of S. pyogenes to utilize arginine was dispensable in the a
167 in the absence of FBP, Pi is an activator of S. pyogenes LDH, E. faecalis LDH1, and L. lactis LDH1 an
168 ered metabolism, the catabolic activities of S. pyogenes strain NZ131 (serotype M49) and an isogenic
169 fibulin-1 may be involved in the adhesion of S. pyogenes to extracellular matrices of the host.
170 hould prove effective for future analyses of S. pyogenes mucosal colonization.
171 sed proteins to identify surface antigens of S. pyogenes.
172 e biochemical and kinetic characteristics of S. pyogenes IMPDH are similar to other bacterial IMPDH e
173 inhibitor ifs from a worldwide collection of S. pyogenes strains.
174 factors for the survival and colonization of S. pyogenes is well established, and many of these facto
175 plicated in non-suppurative complications of S. pyogenes, including glomerulonephritis and rheumatic
176  by how SAgs contribute to the life cycle of S. pyogenes remain poorly understood.
177         We constructed mutant derivatives of S. pyogenes that lack Fba, M1 protein, or both proteins
178 ity factor (SOF), a virulence determinant of S. pyogenes, reduced binding by approximately 50%, and a
179                    However, dissemination of S. pyogenes to the lung was SpyCEP-dependent and was ass
180  the role of prophages in diversification of S. pyogenes and the close relationship between strain Ma
181 ay contribute to the phenotypic diversity of S. pyogenes.
182 ntly protected against the lethal effects of S. pyogenes.
183                      Finally, examination of S. pyogenes following murine subcutaneous infection reve
184            SOF is also a virulence factor of S. pyogenes, but it has not been previously shown to eli
185 oxidase (NOXase) is a unique flavoprotein of S. pyogenes and other lactic acid bacteria which directl
186                                    Growth of S. pyogenes in blood was dependent on the presence of fi
187 ow the intracellular proteome homeostasis of S. pyogenes is influenced by the presence of human plasm
188 novel factors related to the invasiveness of S. pyogenes.
189     This study was a unique investigation of S. pyogenes factors required for successful invasive inf
190 vival of clinical and laboratory isolates of S. pyogenes and S. pneumoniae as both organisms are thou
191                     Although all isolates of S. pyogenes possess the speB gene, not all of them produ
192         We surveyed 384 clinical isolates of S. pyogenes, isolated during 2002-2003, for susceptibili
193 tion, may be present in invasive isolates of S. pyogenes.
194 proximately half of the clinical isolates of S. pyogenes.
195 on that promoted opsonophagocytic killing of S. pyogenes in vitro and provided passive immunity in vi
196  Mrp4, Emm4 and Sof4 promoted the killing of S. pyogenes, but anti-SfbX serum had no effect.
197 t important for survival in a mouse model of S. pyogenes peritoneal infection.
198 resistant isolates from a recent outbreak of S. pyogenes infection in Pittsburgh and in the Lancefiel
199 ibution the toxin has to the pathogenesis of S. pyogenes and that both versions of SPN play an import
200 ulation is necessary for the pathogenesis of S. pyogenes.
201 for the in vivo survival and pathogenesis of S. pyogenes.
202  as titin and fibronectin, the giant pili of S. pyogenes evolved to abrogate mechanical extensibility
203              The putative Rgg polypeptide of S. pyogenes NZ131 consisted of 280 amino acids and had a
204 -moving outbreak highlights the potential of S. pyogenes to cause a range of diseases in the puerperi
205  comparing genomewide transcript profiles of S. pyogenes NZ131 and isogenic derivative NZ131 rgg duri
206                  The encoded HlpA protein of S. pyogenes has 91 amino acids, a predicted molecular ma
207      The well-characterized Scl1 proteins of S. pyogenes show a dichotomous switch in ligand binding
208  important contribution to the regulation of S. pyogenes virulence factors.
209                 We studied the resistance of S. pyogenes to erythromycin and clindamycin at an urban
210 re supernatants from multiple M serotypes of S. pyogenes isolates or a commercially available SLS pre
211 SLS contribute to the subcutaneous spread of S. pyogenes and to a fatal outcome of infection.
212 ophil recruitment during the early stages of S. pyogenes infection.
213 ased SpeB production in a clinical strain of S. pyogenes and relieved its growth phase dependency.
214 igo strain, and not the pharyngeal strain of S. pyogenes or the nonpathogenic S. gorgonii isolate, wa
215 re infected in thigh muscle with a strain of S. pyogenes that expresses a high level of SpyCEP, or wi
216 ized that adherence of an impetigo strain of S. pyogenes would be promoted by terminal differentiatio
217  aspA gene from two different M28 strains of S. pyogenes abrogated their abilities to form biofilms o
218                     Hypervirulent strains of S. pyogenes have evolved a plethora of virulence factors
219 nteractions in attachment of skin strains of S. pyogenes to keratinocytes are unique and remain unide
220 lso differ for throat versus skin strains of S. pyogenes.
221 rence by isogenic M1(+) and M1(-) strains of S. pyogenes.
222 ontributes to the immune evasion strategy of S. pyogenes.
223  the efficacy of antibiotics in treatment of S. pyogenes infections.
224 term stationary-phase survival (>4 weeks) of S. pyogenes.
225 d but not methicillin-resistant S. aureus or S. pyogenes from cellulitis tissue specimens.
226 n with S. dysgalactiae subsp. equisimilis or S. pyogenes.
227 emm, scpA, sic, or cpa (genes encoding other S. pyogenes virulence factors).
228 ed a locus that is highly conserved in other S. pyogenes genomes and is homologous to an operon invol
229                         2) For L. plantarum, S. pyogenes, and E. faecalis, the effects of Pi are dist
230       MPO directly killed H(2)O(2)-producing S. pyogenes but was ineffective against non-H(2)O(2)-pro
231 ss the need for a refined model of prolonged S. pyogenes asymptomatic mucosal colonization, we have a
232 tive form of the streptococcal CXC protease, S. pyogenes cell envelope proteinase, we developed a com
233 olysin, but not SIC, a protein that protects S. pyogenes from CAPs.
234   The polC gene from Streptococcus pyogenes (S. pyogenes, strain SF370) has been cloned and expressed
235  challenged by HRG, sHIP was found to rescue S. pyogenes bacteria.
236 demonstrated that the erythromycin-resistant S. pyogenes comprised multiple strains.
237 ern for the emergence of multidrug-resistant S. pyogenes.
238 s transcribed during cell growth in the same S. pyogenes strain.
239 s question, we discovered that all sequenced S. pyogenes strains possess the genes for the malic enzy
240             As with the previously sequenced S. pyogenes genomes, three unique prophages are a major
241 ed in a small subset of patients with severe S. pyogenes sepsis but not in patients with any other ca
242 st report to show natural induction of sigX, S. pyogenes remained nontransformable under laboratory c
243                           The effector, SPN (S. pyogenes NAD-glycohydrolase), is capable of producing
244 mily ADP-ribosyltransferase designated SpyA (S. pyogenes ADP-ribosyltransferase).
245 AS; Streptococcus pyogenes) protease SpyCEP (S. pyogenes cell envelope protease) cleaves granulocyte
246                            Confirmation that S. pyogenes Cas9 lacks the specificity to discriminate b
247                         We demonstrated that S. pyogenes has an unusually high mRNA turnover rate, wi
248                                We found that S. pyogenes M5-specific antibodies and sera from B. burg
249                          We report here that S. pyogenes is able to bind to bovine submaxillary mucin
250   These findings justify the hypothesis that S. pyogenes infections are more important in the pathoge
251                     These data indicate that S. pyogenes can interact with fibulin-1 and that SOF is
252                  These results indicate that S. pyogenes has evolved multiple mechanisms for invasion
253         Consistent with the observation that S. pyogenes is responsible for a wider variety of human
254                    In addition, we show that S. pyogenes demonstrates an inducible peroxide resistanc
255                      These data suggest that S. pyogenes diversifies during survival in stationary ph
256      Taken together, these data suggest that S. pyogenes requires glutathione peroxidase to adapt to
257  Remarkably, these observations suggest that S. pyogenes uses SAgs to manipulate Vbeta-specific T cel
258                                          The S. pyogenes CAMP factor is specified by a 774-bp open re
259                                          The S. pyogenes M28_Spy1325 polypeptide (designated AspA) di
260                                          The S. pyogenes NAD(+) glycohydrolase (SPN) is a virulence f
261                                          The S. pyogenes tau binds PolC, but the interaction is not a
262  and Northern blot analyses to determine the S. pyogenes mRNA half-life of the transcriptome and to u
263 two-cassette system expressing pieces of the S. pyogenes Cas9 (SpCas9) protein which splice together
264 the highly recombinatorial FCT region of the S. pyogenes genome is under strong selection for change
265 pt that can detect intergenic regions of the S. pyogenes genome.
266 ed the ExPortal, a unique microdomain of the S. pyogenes membrane, specialized for protein secretion
267 rain found that between 3.7 and 28.5% of the S. pyogenes transcripts were differentially expressed, d
268 d partial inhibition of C3 deposition on the S. pyogenes surface.
269 ts with mutually permissive NGGRRT PAMs, the S. pyogenes Cas9 and S. aureus Cas9 yield indels at comp
270 between a known effector of the pathway, the S. pyogenes NAD(+) glycohydrolase (SPN), and a second se
271                     Here, we report that the S. pyogenes cell surface protein Fba can mediate binding
272                        We show here that the S. pyogenes DnaE polymerase also functions with the beta
273  similar and unique features compared to the S. pyogenes enzyme.
274 nto structure-function relationships in this S. pyogenes virulence factor.
275 f SLPI and lysozyme would be advantageous to S. pyogenes in establishing colonization on mucosal surf
276 ontrol protein modules 6 and 7) that bind to S. pyogenes, linked to the Fc region of IgG (FH6-7/Fc).
277 ther, these data show that ME contributes to S. pyogenes' carbon source repertory, that malate utiliz
278 contribute to the binding of hemoproteins to S. pyogenes.
279 tion of Tn5-based transposome mutagenesis to S. pyogenes with initial screening for reduced expressio
280 ate that caspase-1 activation in response to S. pyogenes infection requires NF-kappaB and the virulen
281 e for pro-IL-1beta induction, in response to S. pyogenes infection.
282 both SPN and SLO contribute significantly to S. pyogenes pathogenesis in these virulence assays.
283  subsp. equisimilis isolates were similar to S. pyogenes isolates, in that strains of the same emm ty
284 r1)-deficient mice are highly susceptible to S. pyogenes infection.
285 a-lactam antibiotics, commonly used to treat S. pyogenes infections, do not readily permeate mammalia
286                     In contrast to wild-type S. pyogenes, the SLS- mutant was associated with the rob
287 lerated compared to infection with wild-type S. pyogenes.
288 rmed that the cluster was caused by a unique S. pyogenes clone.
289                                         When S. pyogenes was identified in samples from the epidemic
290 tt and Robin Patel of the Mayo Clinic, where S. pyogenes NAATs have been used for well over a decade
291 ests a novel mechanism of virulence by which S. pyogenes uses its metabolism to modulate innate immun
292       Under experimental conditions in which S. pyogenes is grown in THY medium, the strength of the
293 contributes to the virulence associated with S. pyogenes; however, little is known about its regulati
294  design rules and paired S. aureus Cas9 with S. pyogenes Cas9 to achieve dual targeting in a high fra
295 l infection following a nasal challenge with S. pyogenes M serotype 14.
296 rum IgG, prevented pharyngeal infection with S. pyogenes, and promoted survival.
297 n may be a specific feature of patients with S. pyogenes-induced shock.
298                     Our current results with S. pyogenes Glu-AdT support this characterization of Glu
299  recombinant S5nA acted synergistically with S. pyogenes nuclease A to generate macrophage-toxic deox
300                              For many years, S. pyogenes testing algorithms used a rapid and specific

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top